Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
FibroGen Inc (NASDAQ: FGEN) closed the day trading at $0.37 down -8.07% from the previous closing price of $0.40. In other words, the price has decreased by -$8.07 from its previous closing price. On the day, 0.91 million shares were traded. FGEN stock price reached its highest trading level at $0.3988 during the session, while it also had its lowest trading level at $0.3641.
Ratios:
For a better understanding of FGEN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.24 and its Current Ratio is at 1.41.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2023, Downgraded its rating to Underperform and sets its target price to $2 from $4 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 12 ’24 when Adib Deyaa bought 22,123 shares for $1.17 per share. The transaction valued at 25,884 led to the insider holds 82,123 shares of the business.
Wettig Thane bought 50,000 shares of FGEN for $95,470 on Mar 07 ’24. The CEO now owns 470,178 shares after completing the transaction at $1.91 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FGEN now has a Market Capitalization of 36817048 and an Enterprise Value of 101851968. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.21. Its current Enterprise Value per Revenue stands at 0.586 whereas that against EBITDA is -0.614.
Stock Price History:
Over the past 52 weeks, FGEN has reached a high of $2.93, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is -21.02%, while the 200-Day Moving Average is calculated to be -68.04%.
Shares Statistics:
Over the past 3-months, FGEN traded about 1.79M shares per day on average, while over the past 10 days, FGEN traded about 591870 shares per day. A total of 98.77M shares are outstanding, with a floating share count of 93.37M. Insiders hold about 7.00% of the company’s shares, while institutions hold 56.40% stake in the company. Shares short for FGEN as of 1726185600 were 4771385 with a Short Ratio of 2.67, compared to 1723680000 on 5511064. Therefore, it implies a Short% of Shares Outstanding of 4771385 and a Short% of Float of 5.5999998.
